Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
In this role, Jakobs will lead the global sales and marketing organization
Amsterdam, 13 September 2007 – Elsevier today announced the appointment of Roy Jakobs as Managing Director, Academic and Government Sales and Customer Marketing. In this role, Jakobs will lead the global sales and marketing organization working directly with universities and institutions to provide some of the world’s leading research information solutions, including ScienceDirect, Scopus, bibliographic databases such as the CrossFire Beilstein database, and Elsevier’s extensive collection of online books and reference works.
Jakobs brings to his new position relevant experience in strategic planning, sales and marketing from in- and outside the information solutions industry. He most recently served as Director of Strategy, Science and Technology, at Elsevier. Prior to joining Elsevier in 2005 he held various management roles within Shell in several locations across Europe.
“We have tremendous opportunities to create new value for our customers and end users in the research community,” said Jakobs. “Our customers are engaged in some of the most critically important work there is. My highest priority will be to continue to build on our understanding of their content and workflow needs, and create solutions that help them to be more efficient and more effective.”
Roy Jakobs succeeds Frank Vrancken Peeters, Managing Director A&G Sales and Customer Marketing. Jakobs will continue to report to Herman van Campenhout, CEO Elsevier Science and Technology.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
+ 31 20 485 2736